Research Site

Kasama-shi 309-1793

1 studies enrolling now · 4 studies all time

What they study most

Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Gastroesophageal Junction Adenocarcinoma, HER2-positive Gastric Cancer, IBD, Ulcerative Colitis

Studies at this site

• A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer — Recruiting now
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early
• Open-label Extension Study of Brazikumab in Ulcerative Colitis — Stopped early
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure — Completed